ARCHIVES

FDA To Tighten Up Regulations On Anticancer Drug Combinations, Stop “Permissiveness”

This article is from The Cancer Letter archive.

Vol. 02 No. 36 | September 3, 1976

Download PDF Visit The Full Archive

Related Articles

In Brief: NIH Budget Cut Being Considered, Threatening NCI’s Plan For Reaching Year 2000 Goals

December 13, 1984

In Brief: New Greg For Surgery Research Approved; Only 30 Bioassay Program Reports Still In Backlog

April 21, 1978

Basic Research Group Seeks $7.9 Billion For NIH, $1.7 For NCI

July 24, 1987

Bonner to Succeed Stovall as NCCS President and CEO.

May 30, 2008

Paul Marks To Retire As President, CEO Of Memorial Sloan-Kettering Cancer Center

December 11, 1998

To Industry for Development, NDA

November 18, 1977